Literature DB >> 25199601

Valuing air quality impacts using stated choice analysis: trading off visibility against morbidity effects.

Luis Ignacio Rizzi1, Cristóbal De La Maza2, Luis Abdón Cifuentes3, Jorge Gómez4.   

Abstract

Direct valuation of air quality has as a drawback; that estimated willingness to pay figures cannot be apportioned to the several environmental goods affected by air quality, such as mortality and morbidity effects, visibility, outdoor recreation, among others. To address this issue, we implemented a survey in Santiago de Chile to identify component values of confounded environmental services by means of a choice experiment. We designed a survey where two environmental goods, a morbidity health endpoint and improved visibility, had to be jointly traded off against each other and against money in a unified framework. The health endpoint is a respiratory illness that results in an emergency room visit with a probability of hospitalization being required for appropriate treatment. Visibility is described as an aesthetic effect related to the number of days per year of high visibility. Modeling comprises both a logit model with covariates and a mixed-logit model. The results suggest that the health endpoint midpoint value is in a range from USD 2,800 to USD 13,000, mainly depending on the model and age stratum. The mid point value of an extra day of high visibility per year ranges from USD 281,000 to USD 379,000.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Air pollution; Morbidity; Stated choice analysis; Valuation; Visibility

Mesh:

Year:  2014        PMID: 25199601     DOI: 10.1016/j.jenvman.2014.08.009

Source DB:  PubMed          Journal:  J Environ Manage        ISSN: 0301-4797            Impact factor:   6.789


  1 in total

1.  Interdisciplinary Approaches to Assessing the Health of People Living in Environmentally Adverse Conditions.

Authors:  Yerbol Bekmukhambetov; Arstan Mamyrbayev; Timur Jarkenov; Talgar Abilov; Gulnar Sultanova; Gulnar Isaeva; Mukhtar Zhailybayev; Raisa Uraz
Journal:  Iran J Public Health       Date:  2019-09       Impact factor: 1.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.